Molecular Targeting Technologies, Inc.
2 clinical trials · Sponsor
◉ Watch Molecular Targeting Technologies, Inc.
| Record | Firm | Date |
|---|---|---|
| 177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors (NCT05475210) | Molecular Targeting Technologies, Inc. | 2022-06-18 |
| Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. (NCT00614354) | Molecular Targeting Technologies, Inc. | 2008-10-01 |
Track Molecular Targeting Technologies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.